758
Views
14
CrossRef citations to date
0
Altmetric
Comprehensive Review

A systematic review and meta-analysis of beta-glucan consumption on glycemic control in hypercholesterolemic individuals

, , , &
Pages 355-362 | Received 24 Oct 2014, Accepted 10 Mar 2015, Published online: 22 May 2015

References

  • American Association of Clinical Endocrinologists. 2000. Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management -- 2000 update. Endocr Pract 6:43--84
  • American Diabetes Association. 2004. Standards of medical care in diabetes. Diabetes Care 27:S15–S35
  • Avignon A, Radauceanu A, Monnier L. 1997. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822–1826
  • Baker WL, White CM, Coleman CI. 2008. The role of soluble fiber in the management of patients with hypercholesterolemia: a review of the literature. Conn Med 72:465–468
  • Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
  • Biorklund M, Holm J, Onning G. 2008. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Ann Nutr Metab 52:83–90
  • Biorklund M, van Rees A, Mensink RP, Onning G. 2005. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 59:1272–1281
  • Charlton KE, Tapsell LC, Batterham MJ, O'Shea J, Thorne R, Beck E, Tosh SM. 2012. Effect of 6 weeks' consumption of beta-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults. Br J Nutr 107:1037–1047
  • De Natale C, Minerva V, Patti L, Mazzarella R, Ciano O, Maione S, Luongo D, et al. 2012. Effects of baked products enriched with n-3 fatty acids, folates, beta-glucans, and tocopherol in patients with mild mixed hyperlipidemia. J Am Coll Nutr 31:311–319
  • Degiuseppe JI, Parra GI, Stupka JA. 2014. Genetic diversity of G3 rotavirus strains circulating in argentina during 1998–2012 assessed by full genome analyses. PLoS One 9:e110341
  • Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
  • El-Betagy A. 2005. Food barley: importance, uses and local knowledge. Proceedings of the international workshop on food barley improvement; 2002 Jan 14–17; Hammamet, Tunsia (Aleppo, Syrai: ICARDA)
  • Geogousopoulou EN, Panagiotakos DB, Pitsavos C, Stefanadis C. 2014. Assessment of diet quality improves the classification ability of cardiovascular risk score in predicting future events: the 10-year follow-up of the ATTICA study (2002–2012). Eur J Prev Cardiol. DOI: 10.1177/2047487314555095
  • Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D'Episcopo L, Riccardi G. 2000. Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 23:1461–1466
  • Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB. 2004. Tests of glycemia in diabetes. Diabetes Care 27:1761–1773
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ 327:557–560
  • Hollis S, Campbell F. 1999. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319:670–674
  • Homa K, Majkowska L. 2010. Difficulties in interpreting HbA(1c) results. Pol Arch Med Wewn 120:148–154
  • Institute for Quality and Efficiency in Health Care. 2005. Self-monitoring of urine or blood glucose in diabetes mellitus type 2: executive summary of final report A05-08, Version 1.0. In: Institute for Quality and Efficiency in Health Care: executive Summaries. Cologne, Germany: IQWiG (Institute for Quality and Efficiency in Health Care)
  • Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
  • Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Josse AR, Wong JM, de Souza R, et al. 2005. Direct comparison of dietary portfolio vs statin on C-reactive protein. Eur J Clin Nutr 59:851–860
  • Johansson-Persson A, Ulmius M, Cloetens L, Karhu T, Herzig KH, Onning G. 2014. A high intake of dietary fiber influences C-reactive protein and fibrinogen, but not glucose and lipid metabolism, in mildly hypercholesterolemic subjects. Eur J Nutr 53:39–48
  • Keogh GF, Cooper GJ, Mulvey TB, McArdle BH, Coles GD, Monro JA, Poppitt SD. 2003. Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 78:711–778
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100
  • Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, Hennekens CH, Manson JE. 2000. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 71:1455–1461
  • Lovegrove JA, Clohessy A, Milon H, Williams CM. 2000. Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 72:49–55
  • McIntosh GH, Whyte J, McArthur R, Nestel PJ. 1991. Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men. Am J Clin Nutr 53:1205–1209
  • Monnier L, Lapinski H, Colette C. 2003. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26:881–885
  • Montedori A, Bonacini MI, Casazza G, Luchetta ML, Duca P, Cozzolino F, Abraha I. 2011. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study. Trials 12:58–66
  • Onning G, Wallmark A, Persson M, Akesson B, Elmstahl S, Oste R. 1999. Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab 43:301–309
  • Othman RA, Moghadasian MH, Jones PJ. 2011. Cholesterol-lowering effects of oat beta-glucan. Nutr Rev 69:299–309
  • Panahi S, Ezatagha A, Temelli F, Vasanthan T, Vuksan V. 2007. Beta-glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity. J Am Coll Nutr 26:639–644
  • Pereira MA, O'Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, et al. 2004. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 164:370–376
  • Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL. 2007. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 6:6–13
  • Riccardi G, Rivellese AA. 1991. Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients. Diabetes Care 14:1115–1125
  • Rivellese AA. 2005. Diet and cardiovascular disease: beyond cholesterol. Nutr Metab Cardiovasc Dis 15:395–398
  • Rondanelli M, Opizzi A, Monteferrario F, Klersy C, Cazzola R, Cestaro B. 2011. Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men. Eur J Clin Nutr 65:864–871
  • Standaert B, Ethgen O, Emerson R, Postma M, Mauskopf J. 2014. Comparing cost-effectiveness results for a vaccine across different countries worldwide: what can we learn? Adv Ther 31:1095–1108
  • Talati R, Baker WL, Pabilonia MS, White CM, Coleman CI. 2009. The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med 7:157–163
  • Tiwari U, Cummins E. 2011. Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels. Nutrition 27:1008–1016
  • Wang Q, Ellis PR. 2014. Oat beta-glucan: physico-chemical characteristics in relation to its blood-glucose and cholesterol-lowering properties. Br J Nutr 112:S4–S13
  • Welch RW. 1994. Can dietary oats promote health? Br J Biomed Sci 51:260–270
  • Zhang J, Li L, Song P, Wang C, Man Q, Meng L, Cai J, Kurilich A. 2012. Randomized controlled trial of oatmeal consumption versus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia. Nutr J 11:54–61

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.